Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
Authorized on
Authorized
Remaining
Expires
Terms
30-Oct-26
$50m
$50mEST
n/a
On October 30, 2026, the Company’s Board of Directors approved a one-year extension of the Company's existing stock repurchase program and adjusted the remaining amount authorized under the program up to $ 50.0 million less the amount used under the repurchase program between November 1, 2025 and the close of the market on November 1, 2026.10-Q filed 05-Nov-26
31-Oct-25
$36m
$36m
n/a
On October 31, 2025, the Company’s Board of Directors approved a one-year extension of the Company's existing stock repurchase program. The remaining amount authorized under the program was $35.5 million as of September 30, 2026 and $40.0 million as of December 31, 202510-Q filed 05-Nov-26
Open-market repurchases
Repurchased per month, USD (≈ shares × average price)